When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARVN - Arvinas up 13% on encouraging cancer candidate data
Arvinas Inc.
Thinly traded Arvinas (ARVN+13.2%) is up on double normal volume, albeit on turnover of only 386K shares, on the heels of preliminary data from Phase 1 clinical trials evaluating the safety, tolerability and pharmacokinetics of candidates ARV-110 (metastatic castration-resistant prostate cancer) and ARV-471 (ER+/HER2- locally advanced/metastatic breast cancer).
More news on: Arvinas, Inc., Healthcare stocks news, Stocks on the move,